NTRA News and Press, Natera Inc. From 05/13/20

SAN CARLOS, Calif. , May 13, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 ...

Natera (NASDAQ: NTRA ) reports that it has settled its patent infringement litigation with Illumina (NASDAQ: ILMN ) related to non-invasive prenatal testing (NIPT) and pre-implantation genetic screening and diagnosis activities. More news on: Natera, Inc., Illumina, Inc., Healthcare stoc...

SAN CARLOS, Calif. , May 11, 2020 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Noridian, a Medicare Administrative Contractor (MAC), has issued positive coverage for the Prospera donor-derived cell-free DNA ...

Natera, Inc. (NTRA) Q1 2020 Earnings Conference Call May 6, 2020 4:30 P.M. ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager, Oncology and Transplant Conference Call Participants Dou...

Image source: The Motley Fool. Natera   (NASDAQ: NTRA) Q1 2020 Earnings Call May 06, 2020 , 4:30 p.m. ET Operator Continue reading

ION Geophysical (NYSE: IO ) +87%  on Q1 results . More news on: ION Geophysical Corporation, Tetraphase Pharmaceuticals, Inc., Fastly, Inc., Stocks on the move, , Read more ...

The following slide deck was published by Natera, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Natera (NASDAQ: NTRA ): Q1 GAAP EPS of -$0.45 beats by $0.12 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SAN CARLOS, Calif. , May 6, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2020 and provided an update on recent business progress. Recent...

SAN CARLOS, Calif. , May 4, 2020 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced the achievement of key recruitment milestones in the ProActive registry study and success in the Prospera early access program.&#...